At 5.8x earnings and 6.3x forward earnings, the stock screens as optically cheap, but this is not a clean value story. EPS is $5.40, yet next year’s estimate drops sharply to $3.12, which explains the bloated 22.2 forward PEG and suggests earnings contraction, not growth. The Altman Z-Score of 2.20 puts the company in the grey zone, indicating balance sheet stress rather than financial strength. This is a statistically cheap stock with deteriorating forward fundamentals and moderate distress risk—more of a controversial deep value setup than a clear mispricing.